On its front page, the New York Times (12/11, A1, Schwarz, Subscription Publication) reports in a nearly 1,300-word story on the “rapid” rise of cases in which youngsters “age two or younger are prescribed psychiatric medications to address alarmingly violent or withdrawn behavior.”
Figures from the prescription data company IMS Health reveal that nearly “20,000 prescriptions for risperidone (commonly known as Risperdal), quetiapine (Seroquel) and other antipsychotic medications were written in 2014 for children two and younger, a 50 percent jump from 13,000 just one year before.
Many physicians are concerned that these medications, which are “designed for adults and only warily accepted for certain school-age youngsters, are being used to treat children still in cribs despite no published research into their effectiveness and potential health risks for children so young.” Some experts attribute the increased use of psychiatric medications in kids of all ages to the “scarcity of child psychiatrists.”
Related Links:
— “Still in a Crib, Yet Being Given Antipsychotics,” Alan Schwarz, New York Times, December 10, 2015.